	Radiogenomic inference of transcription factor regulatory architecture associated with a high-risk CT phenotype in Non-Small Cell Lung Cancer. Med Phys Kawahara D, Kishi M, Kadooka Y, Murakami Y. PMID: 42837362 [PubMed - indexed for MEDLINE]
	Pediatric and Adult Sinonasal Phosphaturic Mesenchymal Tumors: CDKN2A Copy Number Alterations and Their Association with Recurrence. Head Neck Pathol Kaur K, Ojha S, Srivastava K, Verma H, Kumar R, Kumar R, Thakar A, Agarwal S, Kakkar A, Bhalla AS, Jain D. PMID: 42837053 [PubMed - indexed for MEDLINE]
	Comment on 'Feasibility study on training dogs to detect lung cancer: findings of a retrospective evaluation'. J Breath Res Ehmann R. PMID: 42837002 [PubMed - in process]
	Reply to Comment on 'Feasibility study on training dogs to detect lung cancer: findings of a retrospective evaluation'. J Breath Res Grah C, Oei SL, Schepanski SN, Wüstefeld H, Blazejczyk K, Kalinka-Grafe J, Seifert G. PMID: 42836978 [PubMed - in process]
	[Personalized drug therapy of metastatic lung cancer]. Inn Med (Heidelb) Stilianakis S, Ruge L, Scharpenseel H, Verheyen M, Wolf J. PMID: 42836958 [PubMed - as supplied by publisher]
	Lung Function-Associated Genetic Variants and Overall Survival in Non-Small Cell Lung Cancer: A Multi-Platform Analysis. Cancer Epidemiol Biomarkers Prev Li Z, Zhang Z, Zhao YC, Su L, Li Y, Christiani DC. PMID: 42836865 [PubMed - as supplied by publisher]
	Redefining leptomeningeal metastasis in non-small cell lung cancer: From terminal complication to molecularly managed disease. Cancer Canaslan K, Pan K, Leal T. PMID: 42836697 [PubMed - indexed for MEDLINE]
	Reclassification of Noncanonical MET Splice-Site Variants Using RNA-Based Validation: A Practical Diagnostic Approach in Non-Small Cell Lung Cancer. Turk Patoloji Derg Mehta A, Saxena R, Pradhan S, Gopalan S, Panigrahi M. PMID: 42836578 [PubMed - as supplied by publisher]
	Genes, fuel, and fate in lung cancer. Biochem Soc Trans Scott JS, Lutz C, Prekovic S. PMID: 42836273 [PubMed - indexed for MEDLINE]
	Mitochondrial metabolic-transcriptional axis drives adaptive drug tolerance across major lung cancer subtypes. Front Genet Liu R, Wang X, Li Z, Mao W, Zhang W, Wang C, Tang Z. PMID: 42836261 [PubMed]
	Ever-smokers in Norway and lung cancer: median time from self-reported smoking debut to lung cancer diagnosis in 11 prospective population studies (CONOR). ERJ Open Res Nguyen OTD, Fotopoulos I, Tsamardinos I, Lagani V, Røe OD. PMID: 42835565 [PubMed]
	Renin-angiotensin system inhibitor use and survival outcomes in lung cancer: a systematic review and meta-analysis. Front Pharmacol Liao Y, Shen J, Liao Y, Lin Y, Zeng N. PMID: 42835318 [PubMed]
	Efficacy and Safety of First-Line Treatment Options for Oncogene Wild-Type Lung Adenocarcinoma With Liver Metastases. Cancer Med Li J, Ge Y, Liu Q, Wei X, Wang J, Wang X, Wang D, Liu J, Sun Y, Gao A. PMID: 42834503 [PubMed - indexed for MEDLINE]
	Epidemiology, exposure patterns and survival of malignant mesothelioma in Apulia, Italy (1993-2025): a population-based retrospective registry study. BMJ Open De Maria L, Cavone D, Delvecchio G, Serio G, Caputi A, Sole S, Aloia G, Lupariello V, Pierfelice A, Sindaco A, Schino V, Stufano A, Vimercati L. PMID: 42833719 [PubMed - indexed for MEDLINE]
	Lung Cancer Screening Beyond Smoking-Based Eligibility: Evidence, Limits, and Lessons From China. Chest He F, Xu Y, Tu B, Liu Y, Ye W, Zeng Y, Powell CA. PMID: 42833546 [PubMed - as supplied by publisher]
	Combined amivantamab, lazertinib, and bevacizumab in patients with EGFR-mutant advanced non-small-cell lung cancer with acquired resistance to a third-generation EGFR tyrosine-kinase inhibitor (ETOP 18-21 AMAZE-lung): a prospective, international, multicentre, single-arm, phase 2 trial. Lancet Respir Med Soo RA, Popat S, Dafni U, de Langen AJ, Nadal E, Iranzo P, Früh M, Pérol M, Metro G, Sala MA, Cucurull Salamero M, Cerciello F, Addeo A, Dómine M, Oulkhouir Y, Cloarec N, López Castro R, Froesch P, Roschitzki-Voser H, Ruepp B, Gasca-Ruchti A, Dellaporta T, Peters S, Stahel RA, ETOP AMAZE-lung collaborators. PMID: 42833236 [PubMed - as supplied by publisher]
	Discordance between physician dose decisions and Cancer and Aging Research Group-defined vulnerability in older adults with lung cancer: A prospective observational study. J Geriatr Oncol Watanabe H, Hirai K, Nakauchi K, Ishii R, Tateishi K, Sonehara K, Araki T, Naito T. PMID: 42833070 [PubMed - as supplied by publisher]
	PLAG1-rearranged pulmonary metastases from pleomorphic adenoma-spectrum salivary gland neoplasms: A clinicopathologic study of metastasizing pleomorphic adenoma and carcinoma ex pleomorphic adenoma. Pathol Res Pract Zhang M, Xu C, Gao X, Du Q, Zheng X, Han J, Chen K, Liu E, Li S. PMID: 42832992 [PubMed - as supplied by publisher]
	EffAtt-LungNet: An attention-guided EfficientNet framework for three-class lung histopathology classification. PLoS One Jamil MA, Awan MDA, Bukhari F, Missen MMS, Kajla NI. PMID: 42832554 [PubMed - indexed for MEDLINE]
	Harmonizing the National Lung Screening Trial: Kernel resolution and field of view compensation. PLoS One Krishnan AR, Kim ME, Gao C, Rudravaram G, Schwartz T, Hucke ATS, Remedios LW, Li TZ, Xu K, Sandler KL, Martinez YF, Antic S, Maldonado F, Zuo L, Landman BA. PMID: 42832530 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 162526

Page 1 of 8127



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy